Novartis Trial Falls Short, Casting Doubt on Heart Disease Treatment
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novartis was first with a trial that fell short.
The failed study raises concerns about a new approach to treating heart disease.
Novartis
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novartis was first with a trial that fell short”
Bloomberg — Failed Study Casts Doubt on Eagerly Awaited New Way to Treat Heart Disease